{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:49:24Z","timestamp":1788544164187,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["261481"],"award-info":[{"award-number":["261481"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.brainres.2021.147303","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T04:18:30Z","timestamp":1611893910000},"page":"147303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Cortical expression of IL1-\u03b2, Bcl-2, Caspase-3 and 9, SEMA-3a, NT-3 and P-glycoprotein as biological markers of intrinsic severity in drug-resistant temporal lobe epilepsy"],"prefix":"10.1016","volume":"1758","author":[{"given":"A.","family":"Vega-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Orozco-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Feria-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Alonso Vanegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Guevara-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2021.147303_b0005","doi-asserted-by":"crossref","unstructured":"Akcali, K.C., Sahiner, M., Sahiner, T., 2005. The rol of Bcl-2 family of genes during kindling. Epilepsia 46 (2), 217\u201323. https:\/\/doi:10.1111\/j.0013-9580.2005.13904.x.","DOI":"10.1111\/j.0013-9580.2005.13904.x"},{"issue":"3","key":"10.1016\/j.brainres.2021.147303_b0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nbd.2011.05.015","article-title":"IL-1\u03b2 is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence","volume":"44","author":"Akin","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.brainres.2021.147303_b0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jocn.2008.08.026","article-title":"Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy-Part. 1","volume":"16","author":"Badawy","year":"2009","journal-title":"J. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2021.147303_b0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jocn.2008.10.001","article-title":"Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy \u2013 Part 2. Review","volume":"16","author":"Badawy","year":"2009","journal-title":"J. Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.brainres.2021.147303_b0025","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1093\/brain\/awn271","article-title":"Novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta","volume":"131","author":"Balosso","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.brainres.2021.147303_b0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","article-title":"The descriptive epidemiology of epilepsy-a review","volume":"85","author":"Banerjee","year":"2009","journal-title":"Epilepsy Res."},{"issue":"5","key":"10.1016\/j.brainres.2021.147303_b0035","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.107.041210","article-title":"Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling","volume":"73","author":"Bauer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2021.147303_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nbd.2017.07.008","article-title":"Time-dependent evolution of seizures in a model of mesial temporal lobe epilepsy","volume":"106","author":"Behr","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.brainres.2021.147303_b0045","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/epi.13870","article-title":"MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: whole miRNome profiling of human hippocampus","volume":"58","author":"Bencurova","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainres.2021.147303_b0050","doi-asserted-by":"crossref","unstructured":"Bruey, J.M., Bruey-Sedano, N., Luciano, F., Zhai, D., Balpai, R., Xu, Ch., Kress, C.L., et al., 2007. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 6; 129 (1), 45\u201356. https:\/\/doi:10.1016\/j.cell.2007.01.045.","DOI":"10.1016\/j.cell.2007.01.045"},{"key":"10.1016\/j.brainres.2021.147303_b0055","first-page":"9:1023","article-title":"Is mossy fiber sprouting a potential therapeutic target for epilepsy?","volume":"30","author":"Cavarsan","year":"2018","journal-title":"Rev. Front. Neurol."},{"issue":"4","key":"10.1016\/j.brainres.2021.147303_b0060","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/jn.1989.61.4.747","article-title":"Horizontal spread of synchronized activity in neocortex and its control by GABA-mediated inhibition","volume":"61","author":"Chagnac-Amitai","year":"1998","journal-title":"J. Neurophysiol."},{"issue":"13","key":"10.1016\/j.brainres.2021.147303_b0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra022308","article-title":"Epilepsy","volume":"349","author":"Chang","year":"2003","journal-title":"Rev. N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.brainres.2021.147303_b0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.brainres.2021.147303_b0075","doi-asserted-by":"crossref","unstructured":"Chung, S., Spruston, N., Koh, S., 2015. Age dependent changes in intrinsic neuronal excitability in subiculum after status epilepticus. PLoS One 10 (3), e0119411. https:\/\/doi 10.1371\/journal.pone.0119411.","DOI":"10.1371\/journal.pone.0119411"},{"key":"10.1016\/j.brainres.2021.147303_b0080","doi-asserted-by":"crossref","unstructured":"Devinsky, O., Vezzani, A., O'Brien, T.J., Jette, N., Scheffer, I.E., de Curtis, M., et al., 2018. Epilepsy. Nat. Rev. Dis. Primers 3; 4, 18024. https:\/\/doi:10.1038\/nrdp.2018.24.","DOI":"10.1038\/nrdp.2018.24"},{"key":"10.1016\/j.brainres.2021.147303_b0085","doi-asserted-by":"crossref","unstructured":"Elliott, C.A., Gross, D.W., Wheatley, B.M., Beaulieu, Ch., Sankar, T., 2016. Progressive contralateral hippocampal atrophy following surgery for medically refractory temporal lobe epilepsy. Epilepsy Res. 125, 62\u201371. https:\/\/doi:10.1016\/j.eplepsyres.2016.06.007.","DOI":"10.1016\/j.eplepsyres.2016.06.007"},{"issue":"2","key":"10.1016\/j.brainres.2021.147303_b0090","first-page":"97","article-title":"Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis?","volume":"1","author":"Engel","year":"2009","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"10.1016\/j.brainres.2021.147303_b0095","doi-asserted-by":"crossref","unstructured":"Fang, M., Xi, Z.Q., Wu, Y., Wang, X.F., 2011. A new hypothesis of drug refractory epilepsy: neural network hypothesis. Med. Hypotheses 76, 871\u2013876. https:\/\/doi:10.1016\/j.mehy.2011.02.039.","DOI":"10.1016\/j.mehy.2011.02.039"},{"key":"10.1016\/j.brainres.2021.147303_b0100","doi-asserted-by":"crossref","unstructured":"Feigin, V.L., Abajobir, A.A., Abate, K.H., Abd-Allah, F., Abdulle, A.M., Abera, S.F., et al., 2017. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.GBD 2015 Neurological Disorders Collaborator Group. Lancet Neurol. 16 (11), 877\u2013897. https:\/\/doi:10.1016\/S1474-4422(17)30299-5.","DOI":"10.1016\/S1474-4422(17)30299-5"},{"issue":"4","key":"10.1016\/j.brainres.2021.147303_b0105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.brainres.2021.147303_b0110","doi-asserted-by":"crossref","unstructured":"French, J.A., 2007. Refractory epilepsy: clinical overview. Epilepsia 48 (1), 3\u20137. https:\/\/doi:10.1111\/j.1528-1167.2007.00992.x14.","DOI":"10.1111\/j.1528-1167.2007.00992.x"},{"issue":"2","key":"10.1016\/j.brainres.2021.147303_b0115","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1152\/physrev.00011.2017","article-title":"Neuronal cell death","volume":"98","author":"Fricker","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.brainres.2021.147303_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yebeh.2005.08.003","article-title":"Prolonged seizures and cellular injury: understanding the connection","volume":"7","author":"Fujikawa","year":"2005","journal-title":"Rev. Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.brainres.2021.147303_b0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.brainres.2006.12.029","article-title":"Caspase-dependent programmed cell death pathways are not activated in generalized seizure-induced neuronal death","volume":"1135","author":"Fujikawa","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2021.147303_b0130","doi-asserted-by":"crossref","unstructured":"Galovic, M., van Dooren, V.Q.H., Postma, T.S., et al., 2019. Progressive cortical thinning in patients with focal epilepsy. JAMA Neurol. 76 (10), 1230\u20131239. https:\/\/doi:10.1001\/jamaneurol.2019.1708.","DOI":"10.1001\/jamaneurol.2019.1708"},{"key":"10.1016\/j.brainres.2021.147303_b0135","doi-asserted-by":"crossref","unstructured":"Gillardon, F., Klimaschewski, L., Wickert, H., Krajewski, S., Reed, J.C., Zimmermann, M., 1996. Expression pattern of candidate cell death effector proteins Bax, Bcl-2, Bcl-X, and c-Jun in sensory and motor neurons following sciatic nerve transection in the rat. Brain Res. 739 (1\u20132), 244\u2013250. https:\/\/doi: 10.1016\/s0006-8993(96)00829-3.","DOI":"10.1016\/S0006-8993(96)00829-3"},{"issue":"2","key":"10.1016\/j.brainres.2021.147303_b0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.55.2.250","article-title":"Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy","volume":"55","author":"Henshall","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.brainres.2021.147303_b0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coph.2007.07.005","article-title":"Modulators of neuronal cell death in epilepsy","volume":"8","author":"Henshall","year":"2008","journal-title":"Rev. Curr Opin Pharmacol."},{"key":"10.1016\/j.brainres.2021.147303_b0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0014-4886(03)00035-9","article-title":"Transient downregulation of sema3a mRNA in a rat model for temporal lobe epilepsy: a novel molecular event potentially contributing to mossy fiber sprouting","volume":"182","author":"Holtmaat","year":"2003","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.brainres.2021.147303_b0155","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/epi.14596","article-title":"The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis","volume":"59","author":"Kalilani","year":"2018","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.brainres.2021.147303_b0160","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/NEN.0000000000000002","article-title":"Neurotrophins in mesial temporal lobe epilepsy with and without psychiatric comorbidities","volume":"72","author":"Kandratavicius","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.brainres.2021.147303_b0165","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.seizure.2012.01.004","article-title":"Elevated serum Bcl-2 in children with temporal lobe epilepsy","volume":"21","author":"Kilany","year":"2012","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.brainres.2021.147303_b0170","first-page":"3990","article-title":"New insights on temporal lobe epilepsy based on plasticity-related network changes and high-order statistics","volume":"55","author":"Kinjo","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2021.147303_b0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-7091-1360-8_1","article-title":"New insight on the mechanisms of epileptogenesis in the developing brain","volume":"39","author":"Kubova","year":"2012","journal-title":"Adv. Tech. Stand. Neurosurg."},{"key":"10.1016\/j.brainres.2021.147303_b0180","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1523\/JNEUROSCI.0064-06.2006","article-title":"Hyperexcitability, interneurons, and loss of GABAergic synapses in entorhinal cortex in a model of temporal lobe epilepsy","volume":"26","author":"Kumar","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2021.147303_b0185","doi-asserted-by":"crossref","unstructured":"Kwan, P., Arzimanoglou, A., Berg, A.T., Brodie, M.J., Hauser, A.W., Mathern, G., et al., 2010. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51 (6), 1069\u20131077. https:\/\/doi:10.1111\/j.1528-1167.2009.02397.x.","DOI":"10.1111\/j.1528-1167.2009.02397.x"},{"key":"10.1016\/j.brainres.2021.147303_b0190","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.brainres.2021.147303_b0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1586\/14737175.6.3.397","article-title":"Refractory epilepsy: mechanisms and solutions","volume":"6","author":"Kwan","year":"2006","journal-title":"Expert Rev. Neurother."},{"issue":"10","key":"10.1016\/j.brainres.2021.147303_b0200","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"Rev. N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.brainres.2021.147303_b0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1152\/jn.00507.2001","article-title":"Synaptic activity in chronically injured, epileptogenic sensory-motor neocortex","volume":"88","author":"Li","year":"2002","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.brainres.2021.147303_b0215","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2006.04.131","article-title":"Inhibition of caspase-8 attenuates neuronal death induced by limbic seizures in a cytochrome c-dependent and Smac\/DIABLO-independent way","volume":"1098","author":"Li","year":"2006","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.brainres.2021.147303_b0220","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research","volume":"62","author":"L\u00f6scher","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.brainres.2021.147303_b0225","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Rev. Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2021.147303_b0230","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","article-title":"Several major antiepileptic drugs are substrates for human P-glycoprotein","volume":"55","author":"Luna-Tort\u00f3s","year":"2008","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.brainres.2021.147303_b0235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000366003","article-title":"Different surgical approaches for mesial temporal epilepsy resection extent, seizure, and neuropsychological outcomes","volume":"92","author":"Malikova","year":"2014","journal-title":"Tereotact. Funct. Neurosurg."},{"key":"10.1016\/j.brainres.2021.147303_b0240","doi-asserted-by":"crossref","unstructured":"Maroso, M., Balosso, S., Ravizza, T., Liu, J., Bianchi, M.E., Vezzani, A. 2011. Interleukin-1 type 1 receptor\/toll-like receptor signalling in epilepsy: the importance of il-1beta and high-mobility group box 1. J. Int. Med. 270 (4), 319\u2013326. https:\/\/doi:10.1111\/j.1365-2796.2011.02431.x.","DOI":"10.1111\/j.1365-2796.2011.02431.x"},{"issue":"4","key":"10.1016\/j.brainres.2021.147303_b0245","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2353\/ajpath.2007.070269","article-title":"Bcl-w protects hippocampus during experimental status epilepticus","volume":"171","author":"Murphy","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2021.147303_b0250","doi-asserted-by":"crossref","unstructured":"Murphy, N., Bonner, H.P., Ward, M.W., Murphy, B.M., Prehn, J.H.M., Henshall, D.C., 2008. Depletion of 14-3-3 zeta elicits endoplasmic reticulum stress and cell death, and increases vulnerability to Kainate-induced injury in mouse hippocampal cultures. J. Neurochem. 106 (2), 978\u2013988. https:\/\/doi:10.1111\/j.1471-4159.2008.05447.x.","DOI":"10.1111\/j.1471-4159.2008.05447.x"},{"key":"10.1016\/j.brainres.2021.147303_b0255","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/WNL.0b013e31822cfc90","article-title":"Incidence of epilepsy: a systematic review and meta-analysis","volume":"77","author":"Ngugi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2021.147303_b0260","doi-asserted-by":"crossref","unstructured":"Organista-Ju\u00e1rez, D., Jim\u00e9nez, A., Rocha, L., Alonso-Vanegas, M, Guevara-Guzm\u00e1n R., 2019. Differential expression of miR-34a, 451, 1260, 1275 and 1298 in the neocortex of patients with mesial temporal lobe epilepsy. Epilepsy Res. 157, 106188. https:\/\/doi:10.1016\/j.eplepsyres.2019.106188.","DOI":"10.1016\/j.eplepsyres.2019.106188"},{"key":"10.1016\/j.brainres.2021.147303_b0265","doi-asserted-by":"crossref","unstructured":"Pekcec, A., Unkruer, B., Schlichtiger, J., Soerensen, J., Hartz, A.M., Bauer, B., van Vliet, E.A., Gorter, J.A., Potschka, H., 2009. Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation. J. Pharmacol. Exp. Ther. 330, 939\u2013947. https:\/\/doi: 10.1124\/jpet.109.152520.","DOI":"10.1124\/jpet.109.152520"},{"key":"10.1016\/j.brainres.2021.147303_b0270","first-page":"106430","article-title":"Drug-resistant epilepsy: from multiple hypotheses to an integral explanation using preclinical resources","volume":"1","author":"P\u00e9rez-P\u00e9rez","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"12","key":"10.1016\/j.brainres.2021.147303_b0275","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/epi.12427","article-title":"Surgical versus medical treatment for refractory epilepsy: outcomes beyond seizure control","volume":"54","author":"Perry","year":"2013","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.brainres.2021.147303_b0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13311-014-0257-2","article-title":"Review past and present definitions of epileptogenesis and its biomarkers","volume":"11","author":"Pitk\u00e4nen","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.brainres.2021.147303_b0285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2018.05.007","article-title":"Epilepsy biomarkers \u2013 toward etiology and pathology specificity","volume":"123","author":"Pitk\u00e4nen","year":"2019","journal-title":"Rev. Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.brainres.2021.147303_b0290","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2217\/pgs.10.126","article-title":"Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches","volume":"11","author":"Potschka","year":"2010","journal-title":"Rev. Pharmacogenom."},{"issue":"12","key":"10.1016\/j.brainres.2021.147303_b0295","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s10541-005-0263-4","article-title":"Immunology of apoptosis and necrosis","volume":"70","author":"Proskuryakov","year":"2005","journal-title":"Rev. Biochem. (Mosc)"},{"key":"10.1016\/j.brainres.2021.147303_b0305","doi-asserted-by":"crossref","unstructured":"Risbud, R.M., Lee, C., and Porter, B.E., 2011. Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus. Brain Res. 2011. 18; 1424, 53\u201359. https:\/\/doi: 10.1016\/j.brainres.2011.09.039.","DOI":"10.1016\/j.brainres.2011.09.039"},{"key":"10.1016\/j.brainres.2021.147303_b0310","doi-asserted-by":"crossref","unstructured":"Rogawski, M.A., Johnson, M.R., 2008. Intrinsic severity as a determinant of antiepileptic drug refractoriness. Epilepsy Curr. 8 (5), 127\u2013130. https:\/\/doi:10.1111\/j.1535-7511.2008.00272.x.","DOI":"10.1111\/j.1535-7511.2008.00272.x"},{"issue":"4","key":"10.1016\/j.brainres.2021.147303_b0315","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s12311-019-01030-8","article-title":"Activation of the extrinsic and intrinsic apoptotic pathways in cerebellum of kindled rats","volume":"18","author":"Rubio","year":"2019","journal-title":"The Cerebellum"},{"issue":"6","key":"10.1016\/j.brainres.2021.147303_b0320","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.seizure.2014.03.003","article-title":"Factors predicting the outcome following medical treatment of mesial temporal epilepsy with hippocampal sclerosis","volume":"23","author":"S\u00e1nchez","year":"2014","journal-title":"Seizures"},{"issue":"4","key":"10.1016\/j.brainres.2021.147303_b0325","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.jcbfm.9600219","article-title":"Caspase-3 cleavage and nuclear localization of caspase-activated DNase in human temporal lobe epilepsy","volume":"26","author":"Schindler","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2021.147303_b0330","doi-asserted-by":"crossref","unstructured":"Schmidt, D., Sillanpaa, M., 2012. Evidence-based review on the natural history of the epilepsies. Curr. Opin. Neurol. 25, 159\u2013163. https:\/\/doi:10.1097\/WCO.0b013e3283507e73.","DOI":"10.1097\/WCO.0b013e3283507e73"},{"key":"10.1016\/j.brainres.2021.147303_b0340","doi-asserted-by":"crossref","unstructured":"Tan, C.C., Zhang, J.G., Tan, M.S., Chen, H., Meng, D.W., et al., 2015. NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced Rat model. 28; 12, 18. https:\/\/doi: 10.1186\/s12974-014-0233-0.","DOI":"10.1186\/s12974-014-0233-0"},{"key":"10.1016\/j.brainres.2021.147303_b0345","doi-asserted-by":"crossref","unstructured":"Tang, F., Hartz, Anika, M.S., Bauer, B., 2017. Drug-resistant epilepsy: multiple hypotheses, few answers. Front. Neurol. 8, 301. https:\/\/doi:10.3389\/fneur.2017.00301.","DOI":"10.3389\/fneur.2017.00301"},{"issue":"10","key":"10.1016\/j.brainres.2021.147303_b0350","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1517\/14656566.8.10.1441","article-title":"Multidrug resistance in epilepsy: a pharmacogenomic update","volume":"8","author":"Tate","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.brainres.2021.147303_b0355","doi-asserted-by":"crossref","first-page":"12447","DOI":"10.1523\/JNEUROSCI.2787-06.2006","article-title":"Modular propagation of epileptiform activity: evidence for an inhibitory veto in neocortex","volume":"26","author":"Trevelyan","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2021.147303_b0360","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.107.121178","article-title":"Region-specific over expression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats","volume":"322","author":"van Vliet","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.brainres.2021.147303_b0365","first-page":"43","article-title":"ICE\/caspase 1 inhibitors and IL-1\u03b2 receptor antagonists as potential therapeutics in epilepsy","volume":"11","author":"Vezzani","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"8","key":"10.1016\/j.brainres.2021.147303_b0370","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Rev. Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2021.147303_b0375","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","article-title":"The role of inflammation in epileptogenesis","volume":"69","author":"Vezzani","year":"2013","journal-title":"Rev. Neuropharmacol."},{"issue":"25","key":"10.1016\/j.brainres.2021.147303_b0380","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","article-title":"Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases","volume":"23","author":"Viviani","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2021.147303_b0385","first-page":"801","article-title":"Monitoring and antiepileptic drug safety","volume":"19","author":"Willmore","year":"2013","journal-title":"Rev. Continuum (Minneap Minn)"},{"issue":"11","key":"10.1016\/j.brainres.2021.147303_b0390","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/syn.20681","article-title":"Gene expression analysis on anterior temporal neocortex of patients with intractable epilepsy","volume":"63","author":"Xi","year":"2009","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.brainres.2021.147303_b0395","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0306-4522(02)00384-6","article-title":"Continuous infusion of neurotrophin-3 triggers sprouting, decreases the levels of TrkA and TrkC, and inhibits epileptogenesis and activity-dependent axonal growth in adult rats","volume":"115","author":"Xu","year":"2002","journal-title":"Neuroscience"},{"issue":"558","key":"10.1016\/j.brainres.2021.147303_b0400","article-title":"The concept of drug-resistance epileptogenic zone","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Neurol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899321000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899321000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T18:15:53Z","timestamp":1757787353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899321000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":77,"alternative-id":["S0006899321000287"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2021.147303","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cortical expression of IL1-\u03b2, Bcl-2, Caspase-3 and 9, SEMA-3a, NT-3 and P-glycoprotein as biological markers of intrinsic severity in drug-resistant temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2021.147303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"147303"}}